Jean Chiou
Overview
Explore the profile of Jean Chiou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang Y, Chan M, Li C, Yang C, Tseng Y, Tsai H, et al.
Cell Death Discov
. 2021 Jun;
7(1):135.
PMID: 34091600
Phosphoglycerate kinase (PGK) is involved in glycolytic and various metabolic events. Dysfunction of PGK may induce metabolic reprogramming and the Warburg effect. In this study, we demonstrated that PGK1, but...
2.
Chang Y, Yang Y, Chiou J, Tsai H, Fang C, Yang C, et al.
Cell Death Dis
. 2020 Mar;
11(3):195.
PMID: 32188842
Drug resistance remains a serious issue of clinical importance and is a consequence of cancer stemness. In this study, we showed that the level of Aldolase A (ALDOA) expression is...
3.
Chiou J, Chang Y, Tsai H, Lin Y, Huang M, Yang C, et al.
Cancer Res
. 2019 Oct;
79(24):6113-6125.
PMID: 31653686
Follistatin-like protein 1 (FSTL1) plays a critical role in lung organogenesis, but is downregulated during lung cancer development and progression. The prognostic significance and functional consequences of FSTL1 downregulation in...
4.
Chiou J, Chang Y, Jan Y, Tsai H, Yang C, Huang M, et al.
Sci Rep
. 2019 Oct;
9(1):14624.
PMID: 31601833
The basic leucine zipper and the W2 domain-containing protein 1 (BZW1) plays a key role in the cell cycle and transcriptionally control the histone H4 gene during G1/S phase. Since...
5.
Chang Y, Chiou J, Yang Y, Su C, Lin Y, Yang C, et al.
Cancer Res
. 2019 Jul;
79(18):4754-4766.
PMID: 31358528
Cancer metabolic reprogramming promotes tumorigenesis and metastasis; however, the underlying molecular mechanisms are still being uncovered. In this study, we show that the glycolytic enzyme aldolase A (ALDOA) is a...
6.
Huang S, Chiou J, Jan Y, Lai T, Yu Y, Hsiao M, et al.
Biochem Biophys Res Commun
. 2018 May;
501(3):619-627.
PMID: 29729273
Lower grade gliomas (LGGs) have highly diverse clinical phenotypes. The histological grade and type are insufficient to accurately predict the clinical outcomes of patients with LGGs. Therefore, identification of biomarkers...
7.
Chiou J, Su C, Jan Y, Yang C, Huang M, Yu Y, et al.
Sci Rep
. 2017 Aug;
7(1):9830.
PMID: 28852126
Follistatin-related protein 1 (FSTL1) plays a critical role in lung development through regulating BMP4-p-Smad1/5/8-Smad4 pathway. Regarding that many developmental pathways in embryogenesis are dysregulated in cancer, we aim to unravel...
8.
Kuo T, Tan C, Chang Y, Hong C, Lee W, Chen M, et al.
J Clin Invest
. 2017 Jan;
127(1):402.
PMID: 28045406
No abstract available.
9.
Su C, Liu Y, Yang C, Lin Y, Chiou J, Chi L, et al.
PLoS One
. 2015 Aug;
10(7):e0133411.
PMID: 26230665
Background: In lung cancer, uPA, its receptor (uPAR), and the inhibitors PAI-1 and PAI-2 of the plasminogen activator family interact with MMP-2 and MMP-9 of the MMP family to promote...
10.
Hong C, Chen P, Chiou J, Chiu C, Yang C, Hsiao M, et al.
Cancer Res
. 2014 Sep;
74(21):6280-90.
PMID: 25205106
Esophageal cancer is an aggressive human malignancy with increasing incidence in the developed world. VEGF-C makes crucial contributions to esophageal cancer progression that are not well understood. Here, we report...